Medidata Blog

DIA 2012 from an @eClinical Perspective

Reading Time: 2 minutes

Hello fellow readers and greetings from the DIA Annual Meeting in Philadelphia. The past three days have been really busy for me. As always, the DIA is the place to be when you are in the world of clinical research. This is my eighth DIA in a row, and by now this conference is part education, part product awareness and part class reunion. The eClinical industry keeps some great people in its ranks, and it was great to catch up with old friends and colleagues. Kudos to Medidata Technology Partner UBC for throwing a great party on the 19th floor of the Hyatt at the Bellevue last night. It wouldn’t be DIA without one of these!

I participated in a session on Tuesday that focused on some of the new guidance documents coming out around eSource and risk-based monitoring. I used this session to relate my experience and knowledge of eClinical technologies and discuss where current trends are headed in light of these new guidance documents. In short, I like to take any opportunity I can to make a meaningful argument that challenges current thinking, especially when it stunts innovation and puts clinical research even further behind the innovations of Silicon Valley.

Of course, it wouldn’t be a DIA session without the honorable mention of the legendary (lack of) EHR integration. This topic comes up every year, and each time we bring it up nothing new has happened. Sure, we have had some pilots and proven from a technology and standards perspective that it can work, but no one has been able to implement this on an enterprise global scale. It’s really frustrating to watch. In my opinion, the EHR vendors have no incentive (yet) to adapt their systems to work with clinical research. EHR integration works in single-site clinical trials where data never leaves the four walls of a research institute, but the silver bullet is to share that data in a multi-center global trial to improve recruitment and eliminate data entry from paper CRFs into EDC. As a result of this lack of innovation, eSource systems are starting to pop up that are generating a new buzz in our industry. What has your experience been with this? Has your company done anything to make strides in utilizing EHR data in clinical trials? What about reducing or nearly eliminating source data verification? If yes, I want to hear from you.  Read more

Check out Joe’s related DIA post, Bringing My Dad to DIA 2012

Check out Joe’s earlier blog post, If They Cooperate, They Will Cure

Guest blogger Joe Dustin is a senior business consultant at Medidata Solutions. You can reach Joe by email or follow him on Twitter @eClinical.

Jacob Angevine